NASH Drug Discovery

NASH Drug Discovery
Version:
21024

Year:
2022

 

In Vitro Panels to Evaluate Drug Candidates

Test your NASH drug candidates with in vitro panels of liver steatosis, hepatitis and liver fibrosis. Each panel contains clinically relevant targets that help to provide insight into the complex nature of NASH pathogenesis. All targets in these panels are also available to be tested individually.